- Home
- OMCL vs RXRX Comparison
OMCL vs RXRX Comparison
Compare OMCL & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMCL
- RXRX
- Stock Information
- Founded
- OMCL 1992
- RXRX 2013
- Country
- OMCL United States
- RXRX United States
- Employees
- OMCL N/A
- RXRX N/A
- Industry
- OMCL Computer Manufacturing
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- OMCL Technology
- RXRX Health Care
- Exchange
- OMCL Nasdaq
- RXRX Nasdaq
- Market Cap
- OMCL 2.0B
- RXRX 2.6B
- IPO Year
- OMCL 2001
- RXRX 2021
- Fundamental
- Price
- OMCL $44.32
- RXRX $7.21
- Analyst Decision
- OMCL Buy
- RXRX Buy
- Analyst Count
- OMCL 6
- RXRX 5
- Target Price
- OMCL $52.00
- RXRX $9.25
- AVG Volume (30 Days)
- OMCL 513.6K
- RXRX 16.7M
- Earning Date
- OMCL 02-06-2025
- RXRX 02-25-2025
- Dividend Yield
- OMCL N/A
- RXRX N/A
- EPS Growth
- OMCL N/A
- RXRX N/A
- EPS
- OMCL N/A
- RXRX N/A
- Revenue
- OMCL $1,064,205,999.00
- RXRX $65,184,000.00
- Revenue This Year
- OMCL N/A
- RXRX $60.17
- Revenue Next Year
- OMCL $5.24
- RXRX $19.88
- P/E Ratio
- OMCL N/A
- RXRX N/A
- Revenue Growth
- OMCL N/A
- RXRX 37.64
- 52 Week Low
- OMCL $25.12
- RXRX $5.60
- 52 Week High
- OMCL $55.75
- RXRX $15.74
- Technical
- Relative Strength Index (RSI)
- OMCL 46.46
- RXRX 52.64
- Support Level
- OMCL $42.80
- RXRX $6.65
- Resistance Level
- OMCL $44.69
- RXRX $7.86
- Average True Range (ATR)
- OMCL 1.47
- RXRX 0.64
- MACD
- OMCL -0.12
- RXRX -0.00
- Stochastic Oscillator
- OMCL 34.62
- RXRX 66.32
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.